UK MHRA grants marketing approval to Galderma’s nemolizumab to treat prurigo nodularis and atopic dermatitis: United Kingdom Tuesday, February 18, 2025, 14:00 Hrs [IST] The Medi ...
Valneva SE (“Valneva”) announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
UK MHRA approves Sobi’s efanesoctocog alfa to prevent and treat bleeding in children and adults with severe or moderate haemophilia A: United Kingdom Monday, February 17, 2025, ...
A new medicine, Nenolizumab, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat two skin conditions ...
This national approval was granted after an Access Consortium new active substance work-sharing initiative (NASWSI) procedure ...
Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...
Entrada Therapeutics' innovative Endosomal Escape Vehicle platform, poised to revolutionize drug delivery. Click here to read ...
4d
The Punch Newspapers on MSNTackling fake products scourgeSubstandard and falsified medical products severely impact public health, leading to severe and often fatal consequences, ...
Scientists comment on a press release from EDX that gives findings on a new screening test for prostate cancer. Prof Derek Rosario, Consultant Urological Surgeon, Honorary Professor and Clinical ...
Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...
5d
GlobalData on MSNEU reshapes HTAs: is the industry ready for it?New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results